Tolterodine
Drugs For Urinary Frequency and Incontinence
- Drug class
- Drugs For Urinary Frequency and Incontinence
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 26
Overview
Plain-language summary, compiled from the cited regulatory records
Tolterodine is a medication classified as a drug for urinary frequency and incontinence [1]. It is approved for the treatment of overactive bladder, specifically addressing symptoms such as urge urinary incontinence, urgency, and urinary frequency [1].
This medication helps manage the symptoms associated with an overactive bladder. It functions as an antimuscarinic agent [1]. Tolterodine is available in extended-release capsule formulations [1].
Tolterodine is marketed under various brand names. In the twelve months prior to the most recent data update, there were no adverse event reports submitted for this active ingredient [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 24 | May 1, 2026 |
| US United States | FDA | 2 | January 6, 2026 |
GBUnited Kingdom· MHRA
24 products
Uses
Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.
How to take
USUnited States· FDA
2 products
Uses
1 INDICATIONS AND USAGE Tolterodine tartrate extended-release capsules are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency [see Clinical Studies (14) ] . Tolterodine tartrate extended-release capsules are an antimuscarinic indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
( 1 )
How to take
Drug interactions
Known interactions involving Tolterodine. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 540. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL200750357 · revised May 1, 2026
- [2]FDA DailyMed · 0565f75a-3f4f-43… · revised December 14, 2024 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.